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Left ventricular mechanical dysfunction in
diet-induced obese mice is exacerbated
during inotropic stress: a cine DENSE
cardiovascular magnetic resonance study
Christopher M. Haggerty1,2,8*, Andrea C. Mattingly1,2, Sage P. Kramer3, Cassi M. Binkley4,8, Linyuan Jing1,2,8,
Jonathan D. Suever1,2,8, David K. Powell5, Richard J. Charnigo6, Frederick H. Epstein7 and Brandon K. Fornwalt1,2,4,5,8

Abstract
Background: Obesity is a risk factor for cardiovascular disease. There is evidence of impaired left ventricular (LV)
function associated with obesity, which may relate to cardiovascular mortality, but some studies have reported no
dysfunction. Ventricular function data are generally acquired under resting conditions, which could mask subtle
differences and potentially contribute to these contradictory findings. Furthermore, abnormal ventricular mechanics
(strains, strain rates, and torsion) may manifest prior to global changes in cardiac function (i.e., ejection fraction) and
may therefore represent more sensitive markers of cardiovascular disease. This study evaluated LV mechanics under
both resting and stress conditions with the hypothesis that the LV mechanical dysfunction associated with obesity
is exacerbated with stress and manifested at earlier stages of disease compared to baseline.
Methods: C57BL/6J mice were randomized to a high-fat or control diet (60 %, 10 % kcal from fat, respectively) for
varying time intervals (n = 7 – 10 subjects per group per time point, 100 total; 4 – 55 weeks on diet). LV mechanics
were quantified under baseline (resting) and/or stress conditions (40 μg/kg/min continuous infusion of
dobutamine) using cine displacement encoding with stimulated echoes (DENSE) with 7.4 ms temporal resolution
on a 7 T Bruker ClinScan. Peak strain, systolic strain rates, and torsion were quantified. A linear mixed model was
used with Benjamini-Hochberg adjustments for multiple comparisons.
Results: Reductions in LV peak longitudinal strain at baseline were first observed in the obese group after
42 weeks, with no differences in systolic strain rates or torsion. Conversely, reductions in longitudinal strain and
circumferential and radial strain rates were seen under inotropic stress conditions after only 22 weeks on diet.
Furthermore, stress cardiovascular magnetic resonance (CMR) evaluation revealed supranormal values of LV radial
strain and torsion in the obese group early on diet, followed by later deficits.
Conclusions: Differences in left ventricular mechanics in obese mice are exacerbated under stress conditions. Stress
CMR demonstrated a broader array of mechanical dysfunction and revealed these differences at earlier time points.
Thus, it may be important to evaluate cardiac function in the setting of obesity under stress conditions to fully
elucidate the presence of ventricular dysfunction.
Keywords: Cardiovascular magnetic resonance, DENSE, Strain, Stress, Mice, Obesity
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Background
Obesity is a highly prevalent disease [1, 2] that is strongly
associated with increased mortality, primarily due to cardiovascular disease [3]. The linkage between obesity and
cardiovascular-related mortality is multi-factorial: obesity
carries risk factors for atherosclerotic disease, but there
are risk factors independent of atherosclerosis as well [4],
potentially including direct effects on the heart [5, 6]. As a
possible consequence of these direct effects, there is
mounting evidence of decreased left ventricular (LV) cardiac function in the setting of obesity for both humans
[7–9] and mouse models [10–12]. However, numerous
studies have observed no dysfunction in obesity [13–18],
so this issue remains controversial.
One potential explanation for these inconsistent reports is the fact that most assessments of cardiac function are performed under baseline resting conditions,
when the heart is under comparatively little metabolic
demand. Under these conditions, subtle functional differences that manifest with physical exertion or stress
may be masked and difficult to detect. For example,
Calligaris et al. found that fractional shortening and
maximum time rates of pressure development (dP/dt)
were no different between control and obese mice
under baseline conditions, but the contractile response
in the obese subjects was reduced with pharmacologic
stress [11].
Another potential cause for the contradictory findings
surrounding cardiac function in the setting of obesity is
the difference in functional end points studied. Specifically, the majority of studies that rely on measures like ejection fraction or fractional shortening to characterize
cardiac function [13–18] report no dysfunction associated
with obesity, while the majority of studies that quantify
cardiac strains (or other similar measures of ‘cardiac mechanics’) [7–10, 19] report the presence of systolic dysfunction with obesity. Of the two approaches, strain-based
measures are widely regarded as being more sensitive
measures of function, as evidenced by the findings of altered strains in patients with heart failure with preserved
ejection fraction (HFpEF) [20, 21]. Furthermore, LV strains
have been shown to be superior to ejection fraction for
predicting outcomes in patients with cardiovascular disease [22, 23].
Using sensitive measures of cardiac mechanics, the
objectives of the present study were therefore: 1) to
characterize the evolution of systolic cardiac function
(or dysfunction) in mice in response to chronic highfat feeding and in relation to concurrent assessments
of systemic blood pressure, glucose tolerance, and
cardiac remodeling; and 2) to compare cardiac function measures between baseline and inotropic stress
conditions over time. We hypothesized that cardiac
mechanics would progressively worsen in obese mice
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in association with the development of other obesity
co-morbidities, and that inotropic stress would exacerbate this cardiac dysfunction and reveal dysfunction at
earlier stages of disease.

Methods
Animals and diets

All animal procedures conformed to the United States
Public Health Service policies for the humane care and use
of animals, and all procedures were approved by the institutional animal care and use committee at the University of
Kentucky. Male C57Bl/6 mice were purchased from the
Jackson Laboratory (Bar Harbor, ME) and fed either a highfat diet of 60 % calories from fat ad libitum (Research Diets
#D12492), or a low fat control diet with 10 % calories from
fat, ad libitum (Research Diets #D12450B or #D12450J).
Animals were group housed in ventilated cages in a
temperature-controlled room with a 14:10 light:dark cycle
and provided with nesting material (Nestlets® and Envirodry®).
Experiment 1 – longitudinal study of the effects of
chronic high-fat feeding and obesity co-morbidities on
cardiac mechanics

A single set of 20 mice (“Cohort #1”; n = 10 per diet
group) were longitudinally studied with measures of blood
pressure, glucose tolerance, cardiac function and mechanics using cardiovascular magnetic resonance (CMR), and
body composition. For this experiment, CMR only interrogated baseline cardiac function, with no beta-adrenergic
agonism. Tests were performed on alternating intervals
through 54 weeks on diet, as detailed in Table 1. A separate set of 20 mice (“Cohort #2”; n = 10 per diet group) was
also studied using glucose tolerance and baseline CMR
measurements after 3 and 4 weeks on diet, respectively.
This second set was added in order to provide 1) a measure of glucose tolerance at an earlier time point (3 weeks
on diet) and 2) supplemental data at the 4 week CMR
measurement to negate a group-wise difference in heart
rate (which could have affected loading conditions and
therefore peak strains) in the first set of mice.
Experiment 2 – effects of inotropic stress on cardiac
mechanics in obesity

CMR studies were performed at 4, 10, 16, 22, 28, and
55 weeks on diet under maximal inotropic stress conditions (intraperitoneal infusion of 40 μg/kg/min dobutamine) [24]. Independent groups of 20 mice (n = 10 per
diet) were used for each time point, with the exception
of 1 group (“Cohort #2”; See Table 1), which was
scanned at both 22 and 28 weeks on diet. Note that the
Cohort #1 mice were also used for the 55-week
measurement (with n = 7 in the obese group with

Haggerty et al. Journal of Cardiovascular Magnetic Resonance (2015) 17:75

Table 1 Details of study cohorts and measurements
Cohort
#1

Measurement

Time Point (weeks on diet)

Blood Pressure

2a, 5, 9, 13, 17, 21, 25, 29, 33, 37b, 41b,
53b

Glucose Tolerance 7, 11, 15, 19, 23, 27, 32, 36b, 40b, 52b

Cohort
#2

Body
Composition

19, 23, 27, 32, 36b, 40b, 52b

CMR at baseline

4, 10, 16, 22, 28, 34b, 42b, 54b

CMR with stress

55b

Glucose Tolerance 3
CMR at baseline

4

CMR with stress

22, 28

Cohort
#3

CMR with stress

4

Cohort
#4

CMR with stress

10

Cohort
#5

CMR with stress

16
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glucose concentrations were measured with a Breeze2
meter (Bayer HealthCare AG, Leverkusen, Germany) at
0 (this measurement defined as the fasting blood glucose), 15, 30, 60, and 120 min after injection. The area
under the glucose concentration curve (AUC) was
calculated after subtracting the area below the fasting
baseline.
Body composition

Whole body composition (fat mass, lean mass, and
water) was measured with a commercial system (model
100; EchoMRI LLC, Houston, TX). These quantities
were used to derive the percentage of fat mass in total
body mass, as well as the ratio of lean-to-fat mass
percentages.
CMR

All cohorts comprised on 20 subjects (n = 10 per group); aProcedure
Acclimatization, Data not reported; b Reduced numbers in obese group
from attrition

attrition). In total, 100 animal subjects were used for
both experiments.
Blood pressure

Conscious systolic blood pressure was measured using a
volume and pressure-recording tail cuff (CODA System,
Kent Scientific, Torrington, CT) [25]. To minimize stress,
the animals were pre-conditioned to measurementassociated handling prior to study data collection (Week
2), and measurements were made in a quiet room with
only the usual caretaker present. Data were acquired over
five consecutive days at the same time of day during the
light cycle. For a given day, at least 5 passing measurements (of 20) were required to retain the average systolic
pressure for that day. Criteria for acceptance were: 1) the
‘pass/fail’ analysis built into the CODA system software; 2)
a value less than 200 mmHg, unless it was within 1 standard deviation of the remaining passing values; and 3) a
value greater than 50 mmHg, unless it was within 1 standard deviation of the remaining passing values. Finally, if
the standard deviation of the remaining passing values
was greater than 30 mmHg, the data for that day were discarded [25]. Successful readings on at least three of five
days were required to report a value for a given week,
which represented the average of the individual day
averages.
Glucose tolerance

Mice were fasted for 6 h in clean cages and injected intraperitoneally with glucose (1 g/kg body weight). Blood

CMR was performed on a 7-Tesla Bruker ClinScan system
(Bruker, Ettlingen, Germany) equipped with a 4-element
phased array cardiac coil and a gradient system with a
maximum strength of 450 mT · m−1 and a maximum slew
rate of 4500 mT · m−1 · s−1. CMR images were acquired
using the tissue motion-sensitive method known as cine
Displacement Encoding with Stimulated Echoes (DENSE)
[26–28]. In this sequence, a displacement encoding pulse
is applied immediately after the detection of an electrocardiogram R-wave (and during the exhalation phase of the
respiratory cycle), which marks the depolarization of the
ventricles and the onset of contraction. To null signal
from fat, a fat-saturating pulse is applied following the
previous R-wave trigger, before the encoding pulse. The
encoding pulse, which consists of both radiofrequency
and gradient pulses, stores the position-encoded longitudinal magnetization. Through subsequent, successive
applications of a readout module (consisting of a radiofrequency excitation pulse, a displacement decoding gradient, and an interleaved spiral k-space trajectory) the phase
component of the MR signal directly encodes the pixelwise tissue displacement as a function of the cardiac cycle.
In this way, a total of 12–20 frames per cardiac cycle
(dependent on heart rate; repetition time = 7.4 ms) were
acquired with orthogonal in-plane (i.e., ‘x’ and ‘y’) displacement encoded images and the magnitude image. Examples
of these images for a representative mid-ventricular shortaxis slice and long-axis 4-chamber slice are shown in
Fig. 1. Other relevant acquisition parameters included:
field of view = 32 mm, matrix = 128 × 128, slice thickness
= 1 mm, echo time = 1 ms, number of averages = 2, number of spiral interleaves = 36 (1 leave acquired per
heartbeat), and displacement encoding frequency = 0.8–
1.0 cycles/mm.
For the baseline CMR studies, 3 LV short-axis and 2 LV
long-axis DENSE images were acquired. The long-axis images consisted of a standard apical 4-chamber view and a
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Magnitude Image

‘x’-Displacement
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‘y’-Displacement

2D Displacement Vectors
cc

rr

Left

Right

Up

Down

LV Short Axis

ll

Left

Right

Up

Down

LV Long Axis
Fig. 1 Representative DENSE CMR images of a mouse left ventricle (LV) in the short (top) and long axis (bottom) orientations at peak systole. The
far right panel demonstrates the corresponding vector displacement field that can be derived from the phase displacement images (middle
panels), along with the corresponding decomposition into radial (εrr), circumferential (εcc), and longitudinal (εll) strains

2-chamber view, perpendicular to the 4-chamber. The
short-axis images were planned perpendicular to the 4chamber image such that the mid-ventricular slice was
shifted 50 % of the endocardial, end-systolic long-axis
length from the apex; the basal and apical slices were positioned 20 % of that total length above and below the midventricular slice, respectively (range: 1–1.4 mm).
For stress CMR scans, dobutamine was infused into
the peritoneal cavity using an MRI compatible syringe
pump (Harvard Apparatus, Holliston, MA) for 10–20
min (depending on heart rate response) following slice
planning and baseline acquisitions, but prior to and continuously during acquisition of stress DENSE. Three LV
short-axis and 4-chamber DENSE images were acquired
with the same slice planning as described for baseline
studies.
Physiologic monitoring during CMR scans

Anesthesia was induced with isoflurane using a precision
vaporizer delivering 1.5–2.5 % isoflurane in oxygen at a
rate of 1 L · min−1. Three legs were shaved for placement
of cutaneous electrocardiogram electrodes required for
cardiac-gated imaging. During the scan, anesthesia was
maintained with 6–10 % desflurane in oxygen at a flow
rate of 0.2–0.5 L · min−1. A diaphragm was placed on the
abdomen to monitor breathing and to gate image acquisition to respiration (in addition to the cardiac cycle). A
rectal thermometer was used to monitor core
temperature, which was maintained between 36.3 °C and
37.3 °C during the procedure using a heated water

system. All vital signs were continuously monitored with
a fiber optic system (SA Instruments, Inc., Stony Brook,
NY).
Image processing

The DENSE phase images were used to derive quantitative
measures of cardiac mechanics using custom DENSE analysis software in MATLAB (The Mathworks, Inc., Natick,
MA). The basic steps included semi-automatic motionguided segmentation of the myocardium, phase unwrapping, spatial smoothing, temporal fitting of displacements,
and calculations of strain, strain rate, torsion, and synchrony [29–31].
Strains were quantified with the 2-dimensional
Lagrangian finite strain tensor. For radial and circumferential strains (defined with respect to the LV center of
mass), the three short-axis images were partitioned based
on the standardized American Heart Association 16 segment model and a strain vs. time curve was calculated for
each segment. A mean curve was defined by averaging
these segment curves; the peak of the mean curve represents the peak strain reported. Peak longitudinal strain
was similarly defined from the long-axis images and a defined coordinate system; however, the apical segments
covering the bottom one-third of the ventricle were excluded from the analysis. Peak strain rates were calculated
by taking positive and negative peaks of the first temporal
derivative of the mean strain curve. All strains are reported as positive magnitudes to facilitate visual comparisons. Peak torsion [° · cm−1] was defined as the maximal
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slope of a linear regression of instantaneous, spatially averaged myocardial twist angles as a function of the distance
between the three short-axis slices.
To quantify left ventricular volumes, mass, and ejection
fraction, the DENSE magnitude images were segmented at
end-diastole (taken as the last frame of the cardiac cycle
because of insufficient nulling of the blood pool signal in
the first image frame) and end-systole. These contours
were inputted to a custom 3-dimensional surface fitting
algorithm [32] to calculate the volume and mass data.
Briefly, thin-plate spline interpolation was used to fit a
smooth surface to the defined boundary and valve points.
Myocardial density was assumed to be 1.05 g/mL.
Statistics

Blood pressure, glucose tolerance, and body composition
results were interpolated to be defined at the same time
points as the CMR-derived outcome variables. Linear
mixed models were then fit to relate outcome variables
to time and group, allowing each group to have its own
temporal trend and not assuming a specific parametric
form (e.g., linear) for that trend. For the longitudinal
measurements in experiment 1, random effects were included to account for correlations among repeated measurements on the same specimen. The groups’ temporal
trends were tested for equality; if this null hypothesis
was rejected, then post-hoc tests were performed to
compare the groups at various time points using a
Benjamini-Hochberg adjustment for multiple comparisons. Some models were also fit with explanatory variables other than group (e.g., LV mass, glucose AUC, and
body fat%). Version 9.3 of SAS software (SAS Institute,
Cary, NC) was employed for these data analyses. T-tests
were used, as indicated, for select individual comparisons. Pearson correlation coefficients were computed to
report associations between peak strain and other obesity co-morbidities. The significance level was set to 0.05.
Continuous variables are reported in the text as mean
± standard deviation. Where applicable, data are graphically represented using box-and-whisker plots in which
the median is represented by a single horizontal line, the
box represents the inter-quartile range, and the whiskers
represent the range of the data.

Results
Experiment 1- longitudinal study of development of
obesity and co-morbidities (n = 20)

Mice fed the high-fat diet had significantly higher body
mass by the time of the first CMR scan after 4 weeks on
the diet (p = 0.0066 at that time point, p < 0.0001 overall;
Fig. 2a), and this separation increased substantially with
time. By study conclusion (54 weeks on diet), the highfat (obese) group weighed 56.1 ± 5.7 g as compared to
32.5 ± 3.5 g for the low-fat controls. The obese mice also
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had significantly higher percentage of fat mass (Fig. 2b;
45.5 ± 3.4 % vs. 25.2 ± 6.7 % at week 52) and a significantly lower lean:fat mass percentage ratio (Fig. 2c; 1.01
± 0.15 vs. 2.69 ± 1.07 at week 52) compared to the control mice.
Conscious systolic blood pressure measurements via
tail cuff yielded a passing result for each mouse at each
measurement week. The data (Fig. 3a) displayed a diverging trend in weeks 17–29 with the obese group having
higher pressure, but the overall linear mixed model did
not report significant differences (p = 0.13).
Measures of glucose regulation, both with respect to
fasting glucose levels (Fig. 3b) and the glucose tolerance
test area under the curve (AUC; Fig. 3c), were significantly different (worse in obese group; p < 0.0001 overall
for both measures) throughout the study from the earliest evaluation. Separate experiments at week 3 (left of
dashed line in Fig. 3b and c) demonstrated that glucose
intolerance developed prior to the first CMR time point
(p < 0.05 via t-test).
Finally, three subjects from the obese group died during the study (during weeks 34, 41, and 43 respectively),
compared to zero in the control group. The causes of
mortality could not be determined.
Obesity is associated with impaired LV peak strains but
preserved ejection fraction at baseline

Figure 4 compares the average LV peak strains at baseline between groups at each measurement (see also
Additional file 1: Table S1). With the exception of the
primary experimental set of mice at the 4-week measurement (necessitating the inclusion of the second set,
as discussed in the methods), there were no significant
differences in cardiac period between groups at any
time point (see Additional file 1: Table S2). The linear
mixed models analysis reported a statistically significant time*group interaction for all strain dimensions
(p-values reported in the figure). However, after correcting for multiple comparisons, post-hoc differences
between groups at individual time points were only
observed for peak longitudinal strain, for which strains
in the obese group were significantly less than controls
at weeks 42 and 54.
There were no statistically significant differences in peak
strain rates (systolic or diastolic) or peak torsion between
groups over time (Additional file 1: Table S3-S5).
Ventricular mass and volume data are shown in Fig. 5.
LV mass (Fig. 5a) progressively increased throughout
the study for both groups, but was significantly higher
in the obese group. This difference was first detected
after 16 weeks on diet and persisted through the remainder of the study. End-diastolic and end-systolic
volumes (Fig. 5c and d) were similarly higher for the
obese group, although significant individual time point
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Fig. 2 a Total body mass, (b) percent of fat mass, and (c) ratio of
lean mass to fat mass percentages for the obese and control mice
at the indicated times with respect to diet initiation. The obese
group had significantly higher body mass (from week 2, onward)
and percentage of fat mass with a lower lean:fat ratio (from earliest
measurement at week 19)

Body Mass

60

40
[grams]

differences were only observed for end-diastolic volumes. Despite these differences in mass and volumes,
there was no significant difference in ejection fraction
between groups (p = 0.196; Fig. 5b).

20

Association of LV peak strains with obesity co-morbidities
Control
Obese
0

0

B)

10

20
30
40
Weeks on Diet

50

Percent Fat Mass

50

[%]

40
30

Experiment 2 – cardiac mechanics under dobutamine
stress (n = 20 per time point)

20
10
0

19 23 27 32 36 40

52

Weeks on Diet

C)

Mass Ratio

6
5

Lean:Fat

4
3
2
1
0

Table 2 presents Pearson correlation coefficients (unadjusted) and linear mixed model p-values for LV mass,
glucose AUC, and body fat % in relation to LV peak
strains, adjusted for group. Both longitudinal and radial
strains had weak-to-moderate correlation coefficients
with each secondary metric; however, after adjusting for
group, only associations between myocardial mass and
radial strain, as well as glucose AUC and radial strain
were statistically significant. Body fat % was not significantly associated with any strain measure after adjusting
for group.

19 23 27 32 36 40

Weeks on Diet

52

With dobutamine stress, heart rate increased from 441
± 50 beats per minute to 571 ± 29 beats per minute. Increased contractility from baseline was evidenced by decreased end-systolic area (Fig. 6) and generally increased
left ventricular strains (except longitudinal strain), strain
rates, and torsion. There were no statistical differences
in heart rate between groups at peak stress, with the exception of the 55-week measurement in which the obese
group had a slightly blunted heart rate response compared to controls (577 ± 32 vs. 546 ± 25 beats per minute
for controls vs. obese groups, respectively; p = 0.046 by
t-test; Additional file 1: Table S2).
Figure 7 shows the cross-sectional comparison of peak
strains under dobutamine stress for the control and
obese groups with respect to time on diet. Based on linear mixed models analysis, there were overall statistically
significant differences in longitudinal and radial, but not
circumferential strains at peak stress over time. Post-hoc
analysis demonstrated that longitudinal strains were significantly lower in the obese group at 22 and 55 weeks,
whereas radial strains were increased in the obese group
at week 4, but significantly lower by 55 weeks on diet
(see Additional file 1: Table S6).
Figure 8 shows the peak circumferential systolic strain
rates for the baseline (top) and stress (bottom) scans.
While there were no statistical differences in circumferential systolic strain rates at baseline (p = 0.29), there
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Fig. 3 Data for (a) systolic blood pressure, (b) fasting blood glucose,
and (c) glucose clearance area under the curve (AUC) at the
indicated times with respect to diet initiation. Differences in blood
pressure were not statistically significant, while both measures of
glucose tolerance were significantly different throughout the study
(overall and at each individual time point)

Systolic Blood Pressure

190
180

[mmHg]

170
160
150
140
Control

130

Obese
5 9 13 17 21 25 29 33 37 41

53

Weeks on Diet

B)

300

Fasting Blood Glucose

250

[mg/dL]

200
150
100
50

3 7 11 15 19 23 27 32 36 40
p<0.05

C)

52

Weeks on Diet

Glucose AUC

4

[mg•min/dL] x 104

was a statistically significant (p < 0.001) and progressive
decline in circumferential strain rates for the obese mice
at peak stress over time. Post-hoc analysis revealed that
these differences were significant from 22 weeks onward,
while there was a trend (p = 0.09) towards a separation
as early as 16 weeks on diet. Similar trends were observed with respect to radial systolic strain rates at peak
stress (overall, p < 0.001; see also Additional file 1: Table
S7-S8)).
Figure 9 shows peak torsion for the baseline (top) and
stress (bottom) scans. There was no statistical difference between groups with respect to torsion at baseline
(p = 0.30); however, there was a significant difference in
torsion at stress between groups over time (p < 0.001;
Additional file 1: Table S9). Similar to what was observed for radial strain, peak torsion was higher in the
obese group early (week 10), but was ultimately decreased compared to controls by 55 weeks.

3

2

1

3 7 11 15 19 23 27 32 36 40

Weeks on Diet

52

Discussion
While the relationship between obesity and increased
cardiovascular mortality is clear, the effects of obesity on
cardiac function are less understood. Murine models
have been used extensively to help address this shortcoming with conflicting results: many studies have reported
decreased cardiac function [12, 33–36], while others have
found no functional change [13, 14, 18, 37, 38], and some
have even reported improved function [15]. This study
sought to address and to help resolve these discrepancies
by evaluating sensitive and reproducible CMR-based measures of cardiac mechanics at baseline and under inotropic
stress.
The primary findings of this study are as follows. First,
we found no significant difference in baseline ejection
fraction between obese and control mice through a year of
high-fat feeding, in agreement with many investigators
reporting no functional change based on ejection fraction
or fractional shortening. However, assessing cardiac mechanics (strain, strain rate, torsion) with DENSE CMR, we
did see altered systolic function in the obese mice. At
baseline, this dysfunction was characterized by decreased
longitudinal strain after 42 weeks on diet; however, at peak
stress, changes in strains, strain rates, and torsion were all
apparent, with dysfunction present by several measures
after 22 weeks on diet. So even though baseline ejection
fraction was normal, systolic dysfunction was still present
with obesity, which is consistent with what has been
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Average Left Ventricular Peak Strains
A) Longitudinal Strain (p<0.0001)

[%]

14
12
10
8
4

10

16

22

28

34

42

54

p<0.05

B) Radial Strain (p=0.0216)

[%]

50
40
30
4

10

16

22

28

34

42
Control

54
Obese

C) Circumferential Strain (p=0.0216)

[%]

16
14
12
4

10

16

22
28
34
Weeks on Diet

42

54

Fig. 4 Average left ventricular peak strains at baseline in the (a) longitudinal, (b) radial, and (c) circumferential directions at the indicated times
with respect to diet initiation from experiment 1. All strains are reported as positive to facilitate visual comparison (i.e. lower strains imply
impaired function). Linear mixed models reported significant differences between groups for all strain measures over time; however, only
longitudinal strain was reduced in the obese group at individual time points by post-hoc analyses (denoted by stars)

reported in humans [39]. Since cardiac strains are also
better predictors of mortality than ejection fraction [23],
clinical assessments of cardiac function in obesity should
incorporate measures of cardiac mechanics, like peak
strains. In particular, peak longitudinal strain appears to
be a critical assessment in obesity as it was a consistent
discriminator between obese and control mice both at
baseline and under stress in this study. There are also numerous human studies that have reported differences in
longitudinal strain with obesity [8, 40–42]. From our data,
the preferential change in longitudinal strain may be partially related to a relative alteration of the myocardial fiber
arrangement with the modest dilation observed in the
end-diastolic volume. Additionally, lipid infiltration and
mild chronic ischemia and inflammatory signaling preferentially impacting the subendocardial and subepicardial
layers have also been proposed as potential mechanisms
to explain longitudinal strain changes [40]. Additional
work is needed to elucidate the exact mechanisms.

Cardiac mechanics at baseline vs. stress

The use of dobutamine stress in this study produced
several meaningful insights as compared to the knowledge gained solely from evaluations at baseline. First,
cardiac dysfunction was exacerbated with stress. While
temporal differences in peak strains were observed at
baseline, stress scanning additionally uncovered differences/deficiencies in systolic strain rates and torsion. In
both of those cases, these differences appear to be the
result of a loss of contractile reserve function in the
obese group over time, as they were no longer able to increase strain rate or torsion with stress to the elevated
level of the controls. Inhibitory interactions of insulin
with the cardiac β2-adrenergic receptors may play a primary role in this blunted response [43]. These changes
may also be the result of myocardial perfusion defects
with stress, which have also been reported in these mice
around the same time [44]. Additionally, cardiac dysfunction was detectable much earlier in the disease
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Fig. 5 Plots of (a) left ventricular mass, (b) ejection fraction, (c) end diastolic volume, and (d) end systolic volume derived from the DENSE
magnitude images at the indicated times with respect to diet initiation. Mass and volumes were significantly elevated overall in the obese group
(individual time point significant differences indicated by stars), but there was no significant difference in ejection fraction

Table 2 Associationsa of obesity sequelae with LV peak strains

Longitudinal Strain

Radial Strain

Circumferential
Strain
a

Myocardial
mass

Glucose
AUC

Fat% of body
mass

R = −0.34;

R = −0.24;

R = −0.47;

p = 0.407

p = 0.065

p = 0.207

R = −0.32;

R = −0.22;

R = −0.45;

p = 0.025

p = 0.037

p = 0.240

R = −0.03

R = −0.05;

R = −0.25;

p = 0.345

p = 0.091

p = 0.305

Values reported represent un-adjusted Pearson correlation coefficients (R),
and p-values from linear mixed model adjusted for group

process at stress (22 weeks on diet) than at baseline
(42 weeks). Notably, this earlier timeline is more consistent with findings of cardiac dysfunction from previous
studies [10, 36, 44]. Finally, stress scans revealed a pattern of potentially early supranormal cardiac mechanics
in the obese group that was not detected at baseline.
Specifically, elevated radial strain and torsion in the
obese mice compared to controls (weeks 4 and 10, respectively) are intriguing findings that are suggestive of
complex physiologic adaptations, such as insulin growth
signaling and the onset of insulin resistance [45], taking
place at these early stages. Interestingly, studies in obese
children have also reported increased LV radial strain
[46] and torsion [40, 46] compared to lean counterparts.
Additional studies are needed to determine if these findings are linked and, if so, the exact mechanisms underlying those responses.
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Relationship of mechanics to obesity sequelae

A) Baseline

B) Stress

Fig. 6 Representative mid-ventricular short-axis DENSE magnitude
images at end-systole for (a) baseline and (b) stress imaging studies
for a single subject. There is an apparent difference in chamber area
between the two images, which is indicative of the change in
contractility with stress

Fasting glucose levels and peripheral glucose clearance
(AUC) were significantly altered (higher) in the obese
group, indicative of glucose intolerance. These changes
occurred very acutely after introduction of the diet, as
early as 3 weeks, and these differences persisted and expanded during the course of the study. Prior studies have
similarly reported acute changes in glucose tolerance [45].
The confounding role of insulin through interactions with
β2 adrenergic receptors in the heart has already been
noted [43]. Additionally, a recent study reported a therapeutic benefit of a glucagon-like peptide-1 analog, which
regulates glucose metabolism, in reversing cardiac dysfunction in mice [36]. Here, we observed an overall weak
but statistically significant association between glucose
clearance and peak radial strain (a similarly weak correlation of longitudinal strain with glucose clearance was not
significant after adjusting for group membership). These

Average Left Ventricular Peak Strains at Stress
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Fig. 7 Average left ventricular peak strains at stress in the (a) longitudinal, (b) radial, and (c) circumferential directions at the indicated times with
respect to diet initiation from experiment 2. All strains are reported as positive to facilitate visual comparison (i.e. lower strains imply impaired
function). Statistically significant differences between groups by linear mixed models were observed with respect to longitudinal and radial strains
over time, with post-hoc findings of individual time point differences denoted by stars. Longitudinal strain was reduced in the obese group at 22
and 55 weeks; radial strain was increased at week 4, but reduced by week 55
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Fig. 8 Left ventricular circumferential systolic strain rates at baseline (top) and stress (bottom) at the indicated times with respect to diet initiation.
No statistical differences between groups were observed at baseline. Strain rates increased for both groups with stress; however, the obese group
did not maintain this contractile reserve over time and, beginning at week 22, they had significantly lower values than controls
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Fig. 9 Left ventricular peak torsion at baseline (top) and stress (bottom) at the indicated times with respect to diet initiation. No statistical
differences between groups were observed at baseline. Torsion at stress was generally increased compared to baseline, but this response was
significantly different between groups over time by linear mixed models. Torsion was elevated in the obese group at week 10 but reduced in the
obese group by week 55 via post-hoc analysis
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results are supportive of continued investigations into the
role of altered insulin and/or glucose signaling in modulating cardiac function in obesity and the potential for
therapies targeting these pathways.
Using tail cuff measurements, no significant differences in systolic blood pressure were observed, so we
could not reliably evaluate the association of blood
pressure and cardiac mechanics in these mice. Previous
studies using more sensitive telemetry measures of
blood pressure observed differences in male mice at
16 weeks of high-fat feeding [47], so it is likely that
there were differences, which the tail cuff was not sensitive enough to detect [48]. Ideally, future studies
could employ concurrent telemetry and MRI measurements; however, such devices would first need to be
made MR compatible.
Myocardial mass was significantly elevated in the
obese group beginning at 16 weeks on the diet, which
is temporally consistent with presence of elevated blood
pressure via telemetry [47]. This ventricular remodeling
had a significant negative association with peak radial
strain, which makes sense given that a thickened myocardium has to deform less radially to eject blood.
However, no similar associations were present with respect to longitudinal (after adjusting for group membership) or circumferential strains, so the observed
mechanical dysfunction cannot be entirely explained by
this ventricular remodeling.
Figure 10 presents a summary timeline of study findings with respect to impaired cardiac mechanics and
their relationship to obesity sequelae.

Inter-test and inter-observer reproducibility

The inter-test and inter-observer variability characteristics for DENSE-derived measures of strain, torsion, and
synchrony in mice have been previously reported [49].
The DENSE-derived measures reported in this study were
found to have acceptable reproducibility characteristics.
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Limitations

This study was conducted in mice, so the relevance of
our findings with respect to changes in cardiac mechanics in obese humans, and particularly the relevant timing
of the development of dysfunction, needs to be established. However, CMR can be acquired in both humans
and mice, so there is a rare ability with this experimental
protocol to make comparable measurements in human
subjects and directly compare findings. Furthermore,
elucidating the time course of dysfunction in a mouse
model is important for future studies seeking to evaluate
the effectiveness of clinically relevant treatment strategies for reversing this dysfunction in mice at meaningful time points.
Some of the mice used for these experiments were
purchased through Jackson Laboratory’s Diet-Induced
Obesity preconditioning service, which created some discrepancies in age and low-fat control diets. Specifically,
mouse ‘cohorts’ 3–5 were purchased through the preconditioning service and were thus started on the diet at
6 weeks of age and the control diet was not sucrosematched to the high-fat diet. Conversely, ‘cohorts’ 1–2
were started on their respective diets at 3 weeks of age
and the control diet was sucrose-matched to the high-fat
diet. Despite this variation, little, if any, differences were
observed in the results between experiment 1 and baseline
data acquired in experiment 2 (prior to the infusion of dobutamine) for weeks 4–16. Furthermore, the primary
study findings were all based on data collected at or after
22 weeks on diet, at which point the ages and low-fat diets
were consistent between experiments. Therefore, these
differences had minimal effect on the study conclusions.
Finally, blood pressure data were collected using a tail
cuff measurement, which has known limitations for detecting subtle differences in systolic pressure. Therefore,
no quantitative comparison of pressure data to cardiac
mechanics is presented here, even though increased
afterload would be expected to affect cardiac function.
Future studies should determine if pharmacologic

Summary Timeline
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Fig. 10 Summary timeline of study findings with respect to changes in cardiac mechanics and the development of obesity sequelae
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treatment of hypertension in this model has beneficial
effects with regard to altered cardiac mechanics as well.

Conclusions
Diet-induced obesity in mice through one year of highfat feeding results in increased left ventricular mass and
altered left ventricular mechanics, but no significant
change in left ventricular ejection fraction. These functional deficiencies in obesity were accentuated with
pharmacologic stress, which revealed reduced peak
strains, strain rates, and torsion of the left ventricle.
Furthermore, these changes in mechanics were revealed
at earlier stages of disease progression under stress
conditions than at baseline. Along with quantification
of ventricular mass, changes in mechanics may carry
prognostic significance for adverse cardiovascular outcomes related to obesity—further study is needed to explore these links. Under both baseline and stress
conditions, reduced peak longitudinal strain was a
strong discriminator between obese and controls subjects. Therefore clinical evaluations of left ventricular
function in obesity should quantify cardiac mechanics
(strain, strain rate, torsion), particularly peak longitudinal strain, and may also benefit from stress imaging
to better identify early signs of dysfunction.
Additional file
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